clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00847379 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P17 | country | Canada | Q16 |
United States of America | Q30 | ||
Spain | Q29 | ||
Belgium | Q31 | ||
Italy | Q38 | ||
Sweden | Q34 | ||
Germany | Q183 | ||
France | Q142 | ||
Australia | Q408 | ||
United Kingdom | Q145 | ||
Israel | Q801 | ||
P582 | end time | 2010-05-01 | |
P921 | main subject | Becker muscular dystrophy | Q2484592 |
ataluren | Q753330 | ||
P1132 | number of participants | 173 | |
P6153 | research site | Columbia University | Q49088 |
University of Minnesota | Q238101 | ||
Katholieke Universiteit Leuven | Q833670 | ||
University of Utah Health Care | Q56582915 | ||
Hospital Sant Joan de Déu | Q64442914 | ||
Washington University in St. Louis | Q777403 | ||
Alberta Children's Hospital | Q2831698 | ||
Children's Hospital of Eastern Ontario | Q2945735 | ||
Bambino Gesù Hospital | Q3886684 | ||
Children's Hospital of Philadelphia | Q4569202 | ||
Cincinnati Children's Hospital Medical Center | Q5120231 | ||
Duke University Medical Center | Q30279912 | ||
University of Kansas Medical Center | Q33526980 | ||
P580 | start time | 2009-01-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase 2b Extension Study of Ataluren (PTC124) in Subjects With Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy |
Search more.